Absci Strengthens Executive Leadership Team with Strategic Hires to Support Business Growth

Biotechnology industry veterans Dr. Sarah Korman and Nikhil Goel to lead legal and business development teams

VANCOUVER, Wash., July 7, 2021 /PRNewswire/ — Absci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced two strategic hires joining its executive team: Nikhil Goel as Chief Business Officer and Dr. Sarah Korman as General Counsel. These appointments come at a time of significant growth for Absci, as it scales its technology development programs and partnerships and integrates its recent acquisitions of Totient and Denovium.

Nikhil Goel, Chief Business Officer

“As we continue to innovate and expand our work with partners to create new next-generation proteins, Nikhil and Sarah are well-positioned to help us strategically grow our business,” said Sean McClain, founder and CEO of Absci. “Their extraordinary individual expertise, and combined experience building teams, executing…

Read more…